Inhibikase shareholders approve equity plan increase; charter amendment fails

Inhibikase Therapeutics, Inc.

Milton H. Werner re-elected with 2,993,996 votes for, 100,914 withheld.
Ratification of CohnReznick as auditor passed with 4,352,312 for, 21,268 against.
Amendment to 2020 Equity Incentive Plan (increase of 2.5M shares) approved with 2,706,691 for.
Proposal to eliminate 66 2/3% vote requirement for charter amendments failed (2,929,207 for, 120,362 against).
All results include substantial broker non-votes on director election and equity plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.